Syndax Pharmaceuticals SNDX Ratios & Valuation
| FY'25 | FY'24 | FY'23 | FY'22 | ||
|---|---|---|---|---|---|
| Profitability | |||||
| Operating margin | -158.2%+1,276pp | -1,434.4%— | —— | —— | |
| Net margin | -165.4%+1,181pp | -1,346.1%— | —— | —— | |
| Free cash flow margin | -187.2%+974pp | -1,160.9%— | —— | —— | |
| Returns | |||||
| Return on equity | -161.8%-86.1pp | -75.7%-34.7pp | -41%-6.9pp | -34.1%-41.6pp | |
| Return on assets | -45.5%+2.2pp | -47.7%-9.9pp | -37.7%-6.2pp | -31.5%-38.2pp | |
| Return on invested capital | -50.3%+13.5pp | -63.8%+6.5pp | -70.3%-18.1pp | -52.2%-68.3pp | |
| Efficiency | |||||
| Asset turnover | 0.3×+0.2× | 0×— | 0×— | 0×-0.4× | |
| Liquidity | |||||
| Current ratio | 4.4×-1.4× | 5.8×-4.2× | 10×-6.9× | 16.9×-4.8× | |
| Quick ratio | 4.1×-1.7× | 5.8×-4.2× | 10×-6.9× | 16.9×-4.8× | |
| Cash ratio | 1.1×-0.4× | 1.5×-3.6× | 5.1×+2.5× | 2.6×-8.2× | |
| Leverage | |||||
| Debt-to-equity | 5.4×+3.1× | 2.3×+2.3× | 0×0.0× | 0×0.0× | |
| Debt-to-assets | 0.7×-0.3× | 0.9×+0.9× | 0×0.0× | 0×0.0× | |
| Interest coverage | -45,514×— | —— | -1,105.5×-1,057× | -48.4×-62.1× | |
| Per Share | |||||
| Book value per share | $0.75-77.8% | $3.37-57.3% | $7.88+2.4% | $7.69+1.0% | |
| Valuation | |||||
| Market capitalization | $1.83B+61.8% | $1.13B-28.0% | $1.57B-9.6% | $1.73B+46.7% | |
| Enterprise value | $2.04B+24.2% | $1.65B+29.2% | $1.27B-23.3% | $1.66B+72.8% | |
| Price / sales | 10.6×-37.1× | 47.7×— | —— | —— | |
| Price / book | 28.3×+24.3× | 3.9×+1.1× | 2.8×-0.9× | 3.7×+0.8× | |
| EV / sales | 11.8×-57.6× | 69.5×— | —— | —— | |
| Free cash flow yield | -17.7%+6.7pp | -24.4%-14.1pp | -10.2%-2.5pp | -7.7%-10.2pp | |
| Earnings yield | -15.6%+12.6pp | -28.2%-14.9pp | -13.4%-4.7pp | -8.6%-10.7pp |
Chart any of these lines over time, or line them up against competitors.
Compare these in charts →Questions, answered.
- Where do Syndax Pharmaceuticals's ratios come from?
- Every ratio is computed from Syndax Pharmaceuticals's SEC filings — trailing-twelve-month flows over period-end balances. Valuation multiples combine those fundamentals with market data, recomputed each period. Switch between quarterly, annual, and TTM, or open any ratio for its full history and peer comparisons.